🔎 Trials Near Me

Utama › Kanser Paru-paru Bukan Sel Kecil › New York › Staten Island

Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Staten Island, NY

19 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Staten Island (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Mengambil pesertaFasa 3
  • Riverview Medical Center/Booker Cancer Center, Red Bank · 15 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT07388524

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Monmouth, Middletown · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07293247

A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer

Mengambil pesertaFasa 1
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07619339

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07323732

Using Urine Samples to Identify Lung Cancer

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi jauh
Umur 18 hingga 90 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06033248

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT04410796

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Mengambil peserta
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05837767

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Mengambil pesertaFasa 3
  • Memorial Sloan Kettering Monmouth, Middletown · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06500481

Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Monmouth, Middletown · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT01639508

A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer

Mengambil pesertaFasa 1/2
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT07535437

Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer

Mengambil pesertaKajian pemerhatian
  • Memorial Sloan Kettering Monmouth (Consent Only), Middletown · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT05424029

A Study of Ivonescimab in People With Non-Small Cell Lung Cancer

Mengambil pesertaFasa 1/2
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Mei 2026 · NCT07594522

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Mei 2026 · NCT05657873

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Monmouth, Middletown · 12 mi jauh
18 Minutes · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06031688

A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer

Mengambil pesertaFasa 1/2
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Apr 2026 · NCT07535463

Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Mac 2026 · NCT07218601

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Monmouth, Middletown · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Feb 2026 · NCT03808337

A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Feb 2026 · NCT07428044

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Staten Island
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain

Kajian lain di Staten Island

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.